These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3387717)

  • 21. Randomized clinical trials: design and analysis.
    Green SB
    Semin Oncol; 1981 Dec; 8(4):417-23. PubMed ID: 7323813
    [No Abstract]   [Full Text] [Related]  

  • 22. A general implementation of TMLE for longitudinal data applied to causal inference in survival analysis.
    Stitelman OM; De Gruttola V; van der Laan MJ
    Int J Biostat; 2012 Sep; 8(1):. PubMed ID: 22992289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A treatment allocation procedure for sequential clinical trials.
    Begg CB; Iglewicz B
    Biometrics; 1980 Mar; 36(1):81-90. PubMed ID: 7370375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Application of sequential methods in randomized clinical trials with censored response criteria].
    Benichou J; Chastang C
    Rev Epidemiol Sante Publique; 1986; 34(3):196-208. PubMed ID: 3786877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A mixed-effects model for categorical data.
    Beitler PJ; Landis JR
    Biometrics; 1985 Dec; 41(4):991-1000. PubMed ID: 3830263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From trial and error to trial simulation. Part 1: the importance of model-based drug development for antidepressant drugs.
    Santen G; van Zwet E; Danhof M; Della Pasqua O
    Clin Pharmacol Ther; 2009 Sep; 86(3):248-54. PubMed ID: 19657333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation coefficient inference on censored bioassay data.
    Li L; Wang WW; Chan IS
    J Biopharm Stat; 2005; 15(3):501-12. PubMed ID: 15920894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A random effects model for ordinal responses from a crossover trial.
    Ezzet F; Whitehead J
    Stat Med; 1991 Jun; 10(6):901-6; discussion 906-7. PubMed ID: 1876780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EM mixed model analysis of data from informatively censored normal distributions.
    Smith FB; Helms RW
    Biometrics; 1995 Jun; 51(2):425-36. PubMed ID: 7662835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and analysis of intra-subject variability in cross-over experiments.
    Chinchilli VM; Esinhart JD
    Stat Med; 1996 Aug; 15(15):1619-34. PubMed ID: 8858786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Permutation tests for centre effect on survival endpoints with application in an acute myeloid leukaemia multicentre study.
    Biard L; Porcher R; Resche-Rigon M
    Stat Med; 2014 Jul; 33(17):3047-57. PubMed ID: 24676752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inference methods for saturated models in longitudinal clinical trials with incomplete binary data.
    Song JX
    Pharm Stat; 2006; 5(4):295-304. PubMed ID: 17128429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimating overall exposure effects for the clustered and censored outcome using random effect Tobit regression models.
    Wang W; Griswold ME
    Stat Med; 2016 Nov; 35(27):4948-4960. PubMed ID: 27449636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intra-fraction motion of the prostate is a random walk.
    Ballhausen H; Li M; Hegemann NS; Ganswindt U; Belka C
    Phys Med Biol; 2015 Jan; 60(2):549-63. PubMed ID: 25549204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generalized multidimensional dynamic allocation method.
    Lebowitsch J; Ge Y; Young B; Hu F
    Stat Med; 2012 Dec; 31(28):3537-44. PubMed ID: 22736449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of different parametric proportional hazards models for interval-censored data: a simulation study.
    Gong Q; Fang L
    Contemp Clin Trials; 2013 Sep; 36(1):276-83. PubMed ID: 23916917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Understanding the complexity of the Lévy-walk nature of human mobility with a multi-scale cost∕benefit model.
    Scafetta N
    Chaos; 2011 Dec; 21(4):043106. PubMed ID: 22225343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sucralfate versus alginate/antacid in the treatment of peptic esophagitis.
    Evreux M
    Am J Med; 1987 Sep; 83(3B):48-50. PubMed ID: 2821808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical trial designs based on sequential conditional probability ratio tests and reverse stochastic curtailing.
    Tan M; Xiong X; Kutner MH
    Biometrics; 1998 Jun; 54(2):682-95. PubMed ID: 9629648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.